ABSTRACT
This work provides an elaborate characterization of human intestinal fluids (HIF) collected in fasted and fed state conditions. HIF from 20 healthy volunteers ( (fed 0-6.76 mg/ml), DAG (fed 0-3.64 mg/ml), MAG (fasted: 0-1.09 mg/ml; fed 0-11.36 mg/ml), FFA
(fasted: 0-3.86 mg/ml; fed 0.53-15.0 mg/ml), pancreatic lipase (fasted: 26-86 µg/ml; fed 146-415 µg/ml), phospholipase A2 (fasted: 3-6 ng/ml; fed 4.3-27.7 ng/ml), and non-specific esterase activity (fasted: 270-4900 U/ml; fed 430-4655 U/ml). This comprehensive overview may serve as reference data for PBPK modeling and the optimization of biorelevant simulated intestinal fluids for the use in in-vitro dissolution, solubility and permeability profiling.
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INTRODUCTION
Variability in human drug bioavailability is often attributed to variations in hepatic first-pass extraction 1 , body distribution, and kidney excretion. For those orally administered drugs, variability may be further increased by gastrointestinal factors 1 , including interdigestive and postprandial gastrointestinal motility, gastric emptying 2 , and human intestinal fluid (HIF) composition 3 . HIF composition is especially important for its effect on the dissolution and permeation of lipophilic drugs with a limited aqueous solubility, i.e. BCS (biopharmaceutics classification system) class II and IV compounds 4 . Predicting the oral absorption potential of this type of drugs requires in vitro tools for dissolution, solubility and permeability, and physiologically-based pharmacokinetic (PBPK) simulation models that account for HIF composition and its related variability.
The importance of bile salts, pH, phospholipids, lipid degradation products, cholesterol, and enzymatic secretions for absorption is generally accepted. The pH is known to affect drug ionization behavior 5, 6 .
The surfactant properties of bile salts 7 and phospholipids 8, 9 contribute to the solubilization of lipophilic compounds. After intake and enzymatic digestion of a meal, lipolytic hydrolysis products [triacylglycerides (TAG), diacylglycerides (DAG), monoacylglycerides (MAG), and free fatty acids (FFA)] form colloidal structures and are a part of mixed micelles, which impact the solubility/permeability of lipophilic compounds [10] [11] [12] . Cholesterol improves bilayer stability 13 and is incorporated in mixed micelles 14 ; more recently, cholesterol has been shown to affect solubility of several BCS II class drugs 15 .
As HIF is comprised of several constituents, it is prone to a large variability. In addition to intersubject differences, day-to-day fluctuations may also lead to intra-subject variability. Moreover, the dynamic nature of the intraluminal environment, for instance mediated by meal intake and biliary/pancreatic secretions, further enhances complexity. The pronounced variability obviously complicates the definition of simulated intestinal fluids (SIF) 3 . Additionally, several limitations of the currently available literature data on HIF composition hinder a clear consensus on the simulation of HIF composition and its related variability. Data is scattered throughout numerous publications 3, [16] [17] [18] [19] [20] [21] , all focusing on different factors and utilizing different sampling protocols. Fasted and fed state conditions are often collected on separate test days, making it impossible to discriminate between the net effect of food and the intrinsic day-to-day variability in human volunteers. Moreover, the timedependent evolution in HIF composition is usually neglected by using only pooled samples.
This study aims to provide a comprehensive and relevant characterization of the composition of duodenal fluids and its variability. Therefore, pH, individual bile salts, phospholipids, cholesterol, lipid degradation products (TAG, DAG, MAG, and FFA), and enzymatic secretions (pancreatic lipase, phospholipase A 2 , and nonspecific esterase) were analyzed in consecutively collected fasted and fed state, time-dependent aspirates from 20 healthy volunteers. To judge the use of pooled aspirates as representative samples, volunteer pools were also created and analyzed. The data enabled insight into inter-subject and time-dependent intra-subject variability and may contribute to the use of pooled HIF samples and their derived SIF composition for physiologically-based absorption profiling. Figure 1A ). This double-lumen catheter enabled the collection of intestinal fluids by means of a syringe without creating underpressure in the gastrointestinal (GI) tract.
MATERIALS & METHODS

MATERIALS
After an overnight fast of at least 12 hours (no food and only water), the volunteers were given 250 ml of water before initiating the sampling of fasted state intestinal fluids. Following the fasted state, 400 mL of Ensure Plus was ingested to simulate a standard meal; this condition is referred to as the fed state. A glass of 250ml water was consumed 20 minutes after intake of the liquid meal ( Figure 1B ).
After the ingestion of water (both for fasted and fed state), intestinal fluids were sampled every 10 min 
HANDLING OF SAMPLES
All aspirated fluids were kept on ice in closed test tubes till the end of sampling, followed by a 15-min centrifugation at 1500 x g and 4 °C. All samples were stored at -20 °C until further analysis. Aliquots (<1ml) of each sample were stored for characterization. The remainder of the collected fractions was pooled for each volunteer in fasted and fed state (further referred to as volunteer pools). Pools were created immediately after the collection was complete. For a selected set of samples, separate aliquots without Orlistat were collected in order to measure esterase activity; additionally, protease inhibitors were added to aliquots of another set of samples used for lipase quantification.
ANALYSIS OF SAMPLES
pH
The pH of all samples (see Sampling of HIF Section) was measured immediately upon collection (Hamilton Slimtrode); the pH of the volunteer pools was measured immediately after pooling.
PHOSPHOLIPIDS
Total phospholipid levels were determined enzymatically employing the Phospholipids FS kit from DiaSys (Holzheim, Germany). After release by phospholipase D, choline is oxidized by choline oxidase, which generates hydrogen peroxide. Subsequently, peroxidase forms a quinone that was analyzed spectrophotometrically at 570 nm 22 using a Tecan Infinite M200 plate reader (Tecan Group
Ltd., Männedorf, Austria). The assay was used in a 96-well format with a detection limit of 0.1 mM.
Biologically relevant bile salts (TC, TCDC, TDC, GC, GCDC, and GDC) at concentrations of 10 mM each (and combined 60 mM) did not interfere with the assay.
CHOLESTEROL
Total cholesterol was determined enzymatically employing an Amplex® Red cholesterol assay kit from Molecular Probes Invitrogen (Eugene, Oregon, United States). Cholesterol esters are hydrolyzed to free cholesterol by cholesterol esterase. Subsequently, cholesterol is oxidized by cholesterol oxidase to yield hydrogen peroxide. In the final step, hydrogen peroxide reacts with Horse radish peroxidase and Amplex® Red to form resofurin 23 . This reaction product was measured using fluorescence (Tecan Infinite M200 plate reader) with an excitation/emission at 560 nm/590 nm, respectively. The detection limit of the assay was 200 nM.
BILE SALTS
Bile salts were analyzed using a Thermo Fisher Scientific LC-MS/MS system. This system consisted of a TSQ Quantum Access™ triple quadrupole mass analyzer, equipped with an electrospray ionization (ESI) source, and coupled to an Accela™ U-HPLC system (San Jose, CA, USA). Data acquisition and peak integration were performed with the Xcalibur® 2.0.7 and LCquan® 2.5.6
software packages, respectively. For separation, a Kinetex C18 column (1.7 μm, 100 A, 50 × 3 mm)
with an in-line KrudKatcher ultra HPLC filter (PhenomenexR, the Netherlands) was used and the column temperature was kept at 30 °C. The injection volume was 25 μl using a full loop. The flow rate was 450 μl/min and bile salts were eluted using a gradient shown in Table 1A The method validation showed an inter-day repeatability in a HIF standard sample (randomly selected) of <10.5% RSD (relative standard deviation) for the individually determined bile salts; the inter-day RSD for the total bile salt concentration was 5.4%. Samples containing 500 nM or 50 nM (in MeOH) of each individual bile salt showed a RSD of <7.9% or < 11%, respectively. The concentration determined in the HIF standard (stored at -20°C) remained stable for > 12months. The intra-day RSD for individual and total bile salt concentrations in the HIF standard was <8.8%, and 3.6%, respectively.
Samples containing 500 nM or 50 nM displayed an intra-day RSD of <6.0% and <10.7%, respectively.
During each analysis, 4 quality control (QC) samples (50nM, 500nM, 2000nM, and a HIF standard)
were determined at least 5 times spread over the analysis (1 set of controls every 15-25 samples). All QC samples displayed accuracy between 90-110% and RSD <10%, for each individual bile salt.
LIPID CONTENT
After freeze-drying of a 100µl HIF sample, lipids were extracted consistent with the method of Armand et al. 24 Briefly, the freeze dried samples were dissolved in 0.15 M NaCl containing 2% glacial acetic acid. Chloroform/methanol (2:1, v/v) was used as extraction solvent. The lower chloroform layer was evaporated to dryness under a stream of nitrogen. The residue was silylated using BSTFA (20% in pyridine, v/v). After 30 min at 60°C, the sample was dissolved in hexane and analyzed by GC
[Fisons MFC800] with flame ionization detection according to the technique described by Duchateau et al. 25 The column used was a Chrompack, CP-Sil5CB-MS column with a deactivated fused silica precolumn. Samples were injected ''cold-on-column'' and were heated to 360°C with a rate of 10°C/min. Hydrogen was used as carrier gas. The injection volume was 1 μl and total run time was 50 min. Lipids were separated according to carbon number (CN). For our purpose, peaks were integrated individually and combined to obtain one AUC (area under the curve) value for each class of neutral lipids. Peaks in the range of CN 8-18, CN 20-28, CN 30-42, and >CN 44 were assigned to free fatty acids (FFA), monoacylglycerides (MAG), diacylglycerides (DAG), and triacylglycerides (TAG), respectively (using calibration standards of the respective classes). These integration ranges were chosen to minimize overlap between the different lipid classes. The amount of each class was calculated using the respective calibration curve: palmitic acid, mono-palmitin, di-palmitin, and tripalmitin standards were dissolved in hexane and appropriate volumes were evaporated under nitrogen to obtain known amounts of the respective standards. The standards were extracted and silylated identically to the unknown samples.
SPECIFIC ESTERASES: PANCREATIC LIPASE & PHOSPHOLIPASE A 2
Both pancreatic lipase and phospholipase A 2 quantities were determined using a commercially available competitive ELISA from Bluegene (Shanghai, China). Separate aliquots were stored at -20°C and only thawed a maximum of 2 times. Samples were diluted in PBS (pH7.4) containing 5%
(v/v) protease inhibitor cocktail including AEBSF at 104 mM, aprotinin at 80 μM, bestatin at 4 mM, E-64 at 1.4 mM, leupeptin at 2 mM and pepstatin A at 1.5 mM.
NON-SPECIFIC ESTERASE ACTIVTIY
Esterase activity was assayed by measuring the conversion of p-nitrophenyl acetate to p-nitrophenyl which could be analyzed spectrophotometrically at 410 nm 26 (Tecan Infinite M200 plate reader). of 500 µL HIF were separated before addition of Orlistat to avoid inhibition of esterases. These separate aliquots were generated for 10 volunteer pools and for time-dependent samples of 3 volunteers.
RESULTS & DISCUSSION
In this study, human intestinal fluids were collected as a function of time from 20 volunteers in fasted and fed state conditions. All HIF aspirates were characterized for pH, bile salts, phospholipids, cholesterol, and lipid hydrolysis products, all of which may directly affect drug solubility and/or permeability. Additionally, enzymes were assessed that may indirectly affect drug absorption:
secretion of pancreatic lipase and phospholipase A 2 influences the intraluminal environment through lipid and phospholipid degradation; esterase activity plays an important role in the conversion of ester prodrugs. Data are presented both as individual data points and in a time-dependent way.
INDIVIDUAL DATA POINTS
In each volunteer, HIF aspirates were characterized at, on average, 17 out of a possible 18 time points, resulting in a total of 161 and 175 individual data points for fasted human intestinal fluids (FaHIF) and fed human intestinal fluid (FeHIF), respectively. These individual data points are presented in Figure 2 providing insight into the overall duodenal variability in pH, bile salts, phospholipids, cholesterol, and lipid degradation products. This overview clearly shows that some factors are asymmetrically distributed, with mean values surpassing the more appropriate median values. It should be noted that such a distribution complicates the comparison of results with literature as most literature data is based on pooled values and/or average time profiles.
pH
In the fasted state, highly variable pH values were observed, ranging from 3.4 to 8.3 ( Figure 2A ). The mean value amounted to 6.78 and the median value to 6.88. These values are slightly higher than the pH defined for FaSSIF (pH 6.5), but still comparable to literature values (between pH of 6-7 3, 18 ). pH 
BILE SALTS
As illustrated in Figure 2B , bile salt concentrations are characterized by a large variability and an asymmetric distribution. Total fasted state bile salt concentrations range from 0.03 mM to 36.18 mM.
The majority of values are clustered below 5 mM. Due to some extreme bile salt concentrations, the mean total concentration (4.61 mM) exceeds the median value (3.30 mM). Both mean and median are within the reported average range of 1.4-8.1 mM 3, 18 ; the median value observed in this study is similar Variability was not only observed for total bile salt concentrations, but was also reflected in the composition of the individual bile salts between volunteers, as shown in Figure 3A . Each symbol in Figure 3A represents the average of all time-points for a single volunteer. Interestingly, the relative abundance of individual bile salts remained nearly constant over time for all 20 healthy volunteers (illustrated for 4 volunteers in Figure 3B ), and no differences could be observed between fasted and fed state. The observed composition is largely in agreement with other studies 18, 21, 28 . When considering conjugated bile salts, glyco-conjugated bile salts (70%) appeared to be more abundant than tauro-conjugated bile salts (30%); others have reported higher percentages of tauro-conjugates in HIF collected from the duodenum 3, 20 , which might be explained by population differences as we also observed a higher abundance of tauro-conjugates in a few volunteers.
PHOSPHOLIPIDS
In fasted state conditions, phospholipids display a similar asymmetric distribution as bile salts with values ranging from 0.01 mM to 6.33 mM ( Figure 2C) 
CHOLESTEROL
In FaHIF, cholesterol is only present at low concentrations ranging between 0.00 mM and 0.48 mM ( Figure 2D ). As such, there is little difference between mean (0.07 mM) and median (0.08 mM). These Taking into account the dilution by water intake (250ml), chyme, and intestinal secretions, it may suggest that endogenous secretion of cholesterol via bile increases considerably in fed state conditions.
LIPIDS
In FaHIF, the only lipid classes observed are FFA and MAG ( Figure 2E aspirates, advanced lipid degradation was seen, resulting in relatively low DAG and TAG concentrations. Fed state DAG and TAG concentrations were absent in a large amount of aspirates causing an asymmetrical distribution between 0.00 and 3.64 mg/ml, and between 0.00 and 6.76 mg/ml, respectively. Consequently, a substantial difference was observed between mean (0.61 mg/ml, ≈1.04 mM) and median (0.36 mg/ml, ≈0.61 mM) DAG concentrations, as well as between mean (0.81 mg/ml, ≈0.96 mM) and median (0.59 mg/ml, ≈0.70 mM) TAG concentrations.
TIME-DEPENDENT EVOLUTION
The results so far illustrate that the intestine is a highly variable environment, which will definitely impact drug and formulation behavior. As part of this overall variability, several parameters fluctuate as a function of time, as demonstrated in Figure 4 which displays average values for the 20 healthy volunteers. Especially after intake of the meal (at 100 min), a clear time-dependent evolution is seen for pH, bile salts, phospholipids, cholesterol and lipid degradation products (food effect). For none of these factors, fasted state conditions were restored after 90 minutes of sampling in the fed state.
In the fasted state, slightly lower pH values were observed during the first 40 min, which may be attributed to the initially fast transfer of (acidic) gastric contents upon intake of a glass of water ( Figure 4A ). On average, pH fluctuates around 6.5, being slightly higher in FaHIF as compared to
FeHIF. Typically, pH varies more in the fasted state (larger SEM) than in the fed state, which was already demonstrated in Figure 2 . Average concentrations of bile salts ( Figure 4B ) and phospholipids ( Figure 4C ) appear to be relatively stable in the fasted state. Postprandial concentrations increase and are characterized by higher variability. This variability may be attributed to the fact that the release of bile is not continuous, but rather pulsatile. Differences in timing and intensity of these contractions result in strong fluctuations as a function of time and, in some individuals, extreme values (for instance bile salt concentrations up to 86 mM). It is worth mentioning that the ratio of bile salt concentrations over phospholipid concentrations ( Figure 4D ) remained impressively constant in fed state conditions. This contrasts with this ratio observed in fasted state conditions. Cholesterol ( Figure   4E ) enters the duodenum through food intake but especially through bile secretions, thus resulting in a similar profile as observed for bile salts and phospholipids.
As expected, little variation was observed in the basal levels of lipid products in fasted state conditions ( Figure 4F ). Postprandially, FFA and DAG but not TAG and DAG significantly increase (as already demonstrated in Figure 2 ). The majority of lipid species are FFA, which implies a very rapid and effective conversion of TAG into FFA and MAG. It is also interesting to see that total duodenal lipid concentrations appear to be tightly controlled by gastric emptying, as they rarely exceed 15 mg/ml, in agreement with the caloric-dependent gastric release 34 . This also corresponds with a previous study by
Clarysse et al. 30 in which both Ensure Plus and a fat-enriched meal were administered; the higher lipid content in the fat-enriched meal did not result in higher duodenal lipid concentrations as a consequence of this caloric brake 34, 35 .
Finally, it should be noted that food effects on HIF composition will strongly depend on the type and composition of the administered meal. For instance, as compared to the liquid meal used in the present study, solid meals will have a different effect on gastric motility and emptying, most likely resulting in a different time-dependency of the food effect.
VOLUNTEER POOLS
In view of the limited volume collected during sampling of HIF, aspirates from different volunteers are usually combined when using HIF for dissolution, solubility, or permeability studies. In the present study, no general 'population' pool was generated. However, volunteer pools were created by combining aliquots of the time-dependent aspirates per volunteer. For each volunteer, a fasted and fed state pool were made, each representing the average HIF aspirated during the respective 90 min time periods. In Figure 5 , the composition of all volunteer pools is represented, demonstrating high intersubject variability for most factors. Despite an unequal distribution, the pool-derived means ( Figure 5) correspond in general to the mean values obtained from all individual data points ( Figure 2 ). The data presented in Figure 5 illustrate that food effects may significantly vary between volunteers: for bile salt concentrations, for instance, food intake resulted in a 20-fold increase in some volunteers (e.g. HV 6 ), while for others almost no increase (e.g. HV 5 ), or even a decrease (e.g. HV 18 ), was observed.
Considering the high variability observed among the different volunteer pools, it is clear that population pools created from different volunteers can only be useful to evaluate the average effect of HIF on dissolution, solubility and permeation. The use of volunteer pools is critical to explore intersubject differences in drug and formulation performance.
ENZYME SECRETIONS
The parameters discussed so far all have a direct effect on the solubilizing capacity of HIF; however, indirect factors that shape the intestinal environment (e.g. lipases) may pose an additional source of variability in absorption. In addition, intestinal esterases may hydrolyze orally dosed ester prodrugs, which can lead to variations in pharmacokinetic and pharmacodynamic responses to these compounds.
As shown in Figure 6 (A-C), HIF from 10 individual volunteers (pooled samples) were studied for pancreatic lipase, phospholipase A2 and esterase. For 3 volunteers, time profiles were included ( Figure   6 D-F).
PANCREATIC LIPASE
Gastric (5-40%) and pancreatic lipase (40-70%) mediate the degradation of lipids and may, as such, exert an important indirect effect on intestinal drug absorption 16 . As indicated in Figure 6 , fasted state pancreatic lipase concentrations ranged between 23 and 86 µg/ml (mean = 49 ± 21 µg/ml). Pancreatic lipase is reported to have a specific activity of 8000 IU/mg 16 , which means that fasted state HIF has an activity between ≈184 and 690 IU/ml. Postprandially, pancreatic lipase concentration increased 5-10 fold, which is comperable to a 5-fold increase reported by Keller et. al 36 . The observed range from 146 µg/ml (≈1170 IU/ml) to 415 µg/ml (≈3320 IU/ml), with an average of 293 ± 93 µg/ml (≈2350 IU/ml), was in line with reported values between 600-7000 IU 16 . The lack of DAG and TAG at all time-points indicates a potent degradation of TAG by lipases present in the GI tract. Figure 6 -D illustrates that, postprandially, pancreatic lipase is secreted in a similar manner (contraction-wise) as other secretions from the papilla of Vater (e.g. bile salts and phospholipids).
PHOSPHOLIPASE A 2
Phospholipids and lyso-phospholipids each have distinct properties with respect to absorption because lyso-phospholipids are stronger surfactants 9, 37, 38 . Phospholipase A 2 mediates the conversion to the lyso form. Several studies have shown that nearly 90% of phospholipids present in duodenal fluids are lyso-phospholipids 21, 28 . Despite their reported effect on the absorption of vitamin A/E and cholesterol 14, 37 , little is known about duodenal phospholipase A 2 (PLA 2 ) concentrations (only using secretin stimulation 39 ). In fasted state, PLA 2 concentrations ranged between 3 and 6 ng/ml (mean = 4.3 ± 1 ng/ml), which increased approximately 5-fold in fed state conditions with an observed range between 4.3 ng/ml and 27.7 ng/ml (mean = 14.1 ± 7.8 ng/ml). Figure 6 -E illustrates that PLA 2 concentrations increase, on average, in a similar proportion and contraction-like manner as phospholipid concentrations in Figure 4C (4-5 fold).
ESTERASE ACTVITY
The rate of prodrug conversion can indirectly influence the absorption of prodrug or parent drug [40] [41] [42] .
As such esterase activity can introduce another factor of variability for the absorption of orally dosed ester-prodrugs. For the measurement of esterase activity, no Orlistat was added during the collection of the samples as it can inhibit esterase activity 43 . The activity assay is based on conversion of a ''small '' acetate ester, as larger esters are generally converted by specific esterases (e.g. lipases) 26 .
Figure 6 C and F show that, in contrast to lipases, esterases do not differ between fasted (270-4900 U/ml) and fed state (430-4655 U/ml). Non-specific esterases such as carboxyl esterase are expressed in almost all tissues including the duodenum 42 . Hence, concentrations are not only influenced by pancreatic secretions and might even be higher near the intestinal brush border.
CONCLUSION
This work has generated a comprehensive overview of human intestinal fluid composition with an unparalleled insight into its time-, food-and subject-dependent variability. As such, it provides a solid data-set for future development of biorelevant absorption profiling tools. Considering the high interindividual variability, the use of averages might be misleading when simulating HIF composition.
None of the pooled samples mimicked the total average composition that was observed. Therefore, in addition to ''average'' SIF it might be useful to generate SIF for high and low responders, as well as time-dependent variations, to investigate potential effects on drug dissolution, solubility and permeability. Incorporating the observed variations in HIF composition into physiology-and population-based simulation tools will be a vital step towards the improved prediction of variability in intestinal drug absorption.
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